A science of the individual: Implications for a medical school curriculum

Annual Review of Genomics and Human Genetics

Volumn 6, Issue , 2005, Pages 313-330

  Childs, Barton ^a   Wiener, Charles ^a   Valle, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CELL PROTEIN; CHEMOKINE RECEPTOR CCR5; DNA; LOW DENSITY LIPOPROTEIN RECEPTOR; M PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; RNA;

CURRICULUM; DOCTOR PATIENT RELATION; EVOLUTION; GENE; GENETICS; HUMAN GENOME PROJECT; INDIVIDUALITY; MEDICAL SCHOOL; MEDICAL STUDENT; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CURRICULUM; EDUCATION, MEDICAL, UNDERGRADUATE; EVOLUTION; GENETICS, MEDICAL; HUMAN GENOME PROJECT; HUMANS; VARIATION (GENETICS);

EID: 25844480621     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.6.080604.162345     Document Type: Review

References (70)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, et al. 2000. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26:76-81
2. Antonarakis S, Krawczak M, Cooper DN. 2001. The nature and mechanisms of human gene mutations. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 343-77. New York: McGraw Hill
3. Bast RC Jr, Hortobagyi GN. 2004. Individualized care for patients with cancer - A work in progress. N. Engl. J. Med. 351:2865-67
4. Beaudet AL. 2002. Is medical genetics neglecting epigenetics? Genet. Med. 4:399-402
5. Bell J. 2004. Predicting disease using genomics. Nature 429:453-56
6. Bentley DR. 2004. Genomes for medicine. Nature 429:440-45
7. Bjornsson HT, Fallin MD, Feinberg AP. 2004. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20:350-58
8. Brown MS, Goldstein JL. 1974. Familial hypercholesterolemia: defective binding of pipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase assay. Proc. Natl. Acad. Sci. USA 71:788-92
9. Brown MS, Goldstein JL. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
10. Burke W, Zimmern RL. 2004. Ensuring the appropriate use of genetic tests. Nat. Rev. (Genet.) 5:955-59
11. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. 2004. Mapping complex disease loci in whole-genome association studies. Nature 429:446-52
12. Carrington M, Dean M, Martin MP, O'Brien SJ. 1999. Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Hum. Mol. Genet. 8:1939-45
13. Casselbrant ML, Mandel EM, Fall PA, Rockette HE, Kurs-Lasky M, et al. 1999. The heritability of otitis media: a twin and triplet study. JAMA 282:2125-30
14. Chakravarti A, Little P. 2003. Nature, nurture and human disease. Nature 421:412-14
15. Childs B, Huether CA, Murphy EA. 1981. Human genetics teaching in U.S. medical schools. Am. J. Hum. Genet. 33:1-10
16. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. 2004. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-72
17. Collins FS. 2004. The case for a US prospective cohort study of genes and environment. Nature 429:475-77
18. Collins FS, Green ED, Guttmacher AE, Guyer MS. 2003. A vision for the future of genomics research. Nature 422:835-47
19. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, et al. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7:180-84
20. Dobzhansky T. 1973. Nothing in biology makes sense except in the light of evolution. Am. Biol. Teacher 35:125-29
21. Ehrlich GD, Post JC. 1999. Susceptibility to otitis media: strong evidence that genetics plays a role. JAMA 282:2167-69
22. Enard W, Khaitovich P, Klose J, Zöllner S, Heissig F, et al. 2002. Intra- and interspecific variation in primate gene expression patterns. Science 296:340-43
23. Evans WE, Relling MV. 2004. Moving towards individualized medicine with pharmacogenomics. Nature 429:464-68
24. Florez JC, Hirschhorn JN, Altshuler D. 2003. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics Hum. Genet. 4:257-91
25. Freel EM, Connell JM. 2004. Mechanisms of hypertension: the expanding role of aldosterone. J. Am. Soc. Nephrol. 15:1993-2001
26. Fries JF, Crapo LM. 1981. Vitality and Aging: Implication of the Rectangular Curve. San Francisco: W.H. Freeman
27. Fugger L, Tisch R, Libau R, van Endert P, McDevitt HO. 2001. The role of human major histocompatibility complex (HLA) genes in disease. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 311-41. New York: McGraw Hill
28. Glazier AM, Nadeau JH, Aitman TJ. 2002. Finding genes that underlie complex traits. Science 298:2345-49
29. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG. 1973. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 52:1533-43
30. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. 1973. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52:1544-68
31. Haga SB, Khoury MJ, Burke W. 2003. Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat. Genet. 34:347-50
32. Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cézard J-P, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
33. 32a. International HapMap Corsortium. 2003. The international HapMap project. Nature 426:789-96
34. International Human Genome Sequencing Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-45
35. Jaakson K, Zernant J, Külm M, Hutchinson A, Tonisson N, et al. 2003. Genotyping microarray (gene chip) for the ABCR (ABCR4) gene. Hum. Mutat. 22:395-403
36. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl.):245-54
37. Jimenez-Sanchez G, Childs B, Valle D. 2001. Human disease genes. Nature 409:853-55
38. Johnson VA, Brun-Vezinet F, Clotet B, Conway B, D'Aquila RT, et al. 2005. Update of the drug resistance mutations in HIV-1. Top. HIV Med. 13:1581-83
39. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. 2004. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann. Intern. Med. 140:330-37
40. Korf BR. 2002. Integration of genetics into clinical teaching in medical school education. Genet. Med. 4:33S-38S
41. Lusis AJ, Mar R, Pajukanta P. 2004. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 5:189-218
42. Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, et al. 2000. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67:383-94
43. Mata NL, Tzekov RT, Liu X, Weng J, Birch DG, Travis GH. 2001. Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42:1685-90
44. Mayr E. 1961. Cause and effect in biology. Science 134:1501-6
45. Merikangas KR, Risch N. 2003. Will the genomics revolution revoluntionize psychiatry? Am. J. Psychiatry 160:625-35
46. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. 2004. Genetic analysis of genome-wide variation in human gene expression. Nature 430:743-47
47. Naber CK, Siffert W. 2004. Genetics of human arterial hypertension. Minerva Med. 95:347-56
48. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-6
49. Ostrander EA, Markianos K, Stanford JL. 2004. Finding prostate cancer susceptibility genes. Annu. Rev. Genomics Hum. Genet. 5:151-76
50. Paik S, Shak S, Tang G, Kim C, Baker J, et al. 2004. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351:2817-26
51. Panzer U, Schneider A, Steinmetz OM, Wenzel U, Barth P, et al. 2005. The chemokine receptor 5 D32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int. 67:75-81
52. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, et al. 2004. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36:471-75
53. Penrose LS. 1950. Value of genetics in medicine. Br. Med. J. 2:903-5
54. Rader DJ, Cohen J, Hobbs HH. 2003. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J. Clin. Invest. 111:1795-803
55. Reich D, Lander ES. 2001. On the allelic spectrum of human disease. Trends Genet. 17:502-10
56. Riccardi VM, Schmickel RD. 1988. Human genetics as a component of medical school curricula: a report to The American Society of Human Genetics. Am. J. Hum. Genet. 43:639-43
57. Ridanpaa M, van Eenennaam H, Pelin K, Chadwick RB, Johnson C, et al. 2001. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104:195-203
58. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405:847-56
59. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. 1995. High risk of thrombosis in patients homozygous for Factor V Leiden (activated protein C resistance), Blood 85:1504-8
60. Roses AD. 2000. Pharmacogenetics and the practice of medicine. Nature 405:857-65
61. Schelleman H, Stricker BH, DeBoer A, Kroon AA, Verschuren MW, et al. 2004. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 64:1801-16
62. Scriver CR, Kaufman S. 2001. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle. pp. 1667-724. New York: McGraw Hill
63. Scriver CR, Waters PJ. 1999. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 15:267-72
64. Temkin O. 1963. The scientific approach to disease: specific entity and individual sickness. In Scientific Change, ed. AC Crombie, pp. 629-55. New York: Basic Books
65. Allikmets R, Shroyer F, Singh N, Seddon JM, Lewis RA, et al. 1997. Mutation of Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277:1805-7
66. Tishkoff SA, Verrelli BC. 2003. Patterns of human genetic diversity, implications for human evolutionary history and disease. Annu. Rev. Genomics Hum. Genet. 4:293-340
67. Tishkoff SA, Williams SM. 2002. Genetic analysis of African populations: human evolution and complex disease. Nat. Rev. (Genet.) 3:611-21
68. Valle D. 2004. American Society of Human Genetics Presidential Address 2003: Genetics, individuality and medicine in the 21st century. Am. J. Hum. Genet. 74:374-81
69. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, et al. 2003. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. USA 100:1896-901
70. Wright S. 1959. Genetics and the hierarchy of biological sciences. Science 130:959-65